Global Primary Biliary Cirrhosis Drug Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3484120
- 92 Pages
- February 2020
- Healthcare
The global Primary Biliary Cirrhosis Drug market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Primary Biliary Cirrhosis Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Johnson & Johnson
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Clinic
Hospital
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Primary Biliary Cirrhosis Drug Industry
Figure Primary Biliary Cirrhosis Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Primary Biliary Cirrhosis Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Primary Biliary Cirrhosis Drug
1.2.2 Downstream
Table Application Segment of Primary Biliary Cirrhosis Drug
Table Global Primary Biliary Cirrhosis Drug Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Primary Biliary Cirrhosis Drug Market by Type
3.1 By Type
3.1.1 Budesonide
Table Major Company List of Budesonide
3.1.2 FFP-104
Table Major Company List of FFP-104
3.1.3 GSK-2330672
Table Major Company List of GSK-2330672
3.1.4 MBX-8025
Table Major Company List of MBX-8025
3.1.5 NGM-282
Table Major Company List of NGM-282
3.1.6 Others
Table Major Company List of Others
3.2 Market Size
Table Global Primary Biliary Cirrhosis Drug Market 2015-2019, by Type, in USD Million
Figure Global Primary Biliary Cirrhosis Drug Market Growth 2015-2019, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2015-2019, by Type, in Volume
Figure Global Primary Biliary Cirrhosis Drug Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2020-2025, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 AlbireoPharma (Company Profile, Sales Data etc.)
4.1.1 AlbireoPharma Profile
Table AlbireoPharma Overview List
4.1.2 AlbireoPharma Products & Services
4.1.3 AlbireoPharma Business Operation Conditions
Table Business Operation of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 CymaBay Therapeutics, Inc. (Company Profile, Sales Data etc.)
4.2.1 CymaBay Therapeutics, Inc. Profile
Table CymaBay Therapeutics, Inc. Overview List
4.2.2 CymaBay Therapeutics, Inc. Products & Services
4.2.3 CymaBay Therapeutics, Inc. Business Operation Conditions
Table Business Operation of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Dr. Falk Pharma GmbH (Company Profile, Sales Data etc.)
4.3.1 Dr. Falk Pharma GmbH Profile
Table Dr. Falk Pharma GmbH Overview List
4.3.2 Dr. Falk Pharma GmbH Products & Services
4.3.3 Dr. Falk Pharma GmbH Business Operation Conditions
Table Business Operation of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Enanta Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.4.1 Enanta Pharmaceuticals, Inc. Profile
Table Enanta Pharmaceuticals, Inc. Overview List
4.4.2 Enanta Pharmaceuticals, Inc. Products & Services
4.4.3 Enanta Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.5.1 GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Overview List
4.5.2 GlaxoSmithKline Plc Products & Services
4.5.3 GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Intercept Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.6.1 Intercept Pharmaceuticals, Inc. Profile
Table Intercept Pharmaceuticals, Inc. Overview List
4.6.2 Intercept Pharmaceuticals, Inc. Products & Services
4.6.3 Intercept Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Johnson & Johnson (Company Profile, Sales Data etc.)
4.7.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.7.2 Johnson & Johnson Products & Services
4.7.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 MediGene AG (Company Profile, Sales Data etc.)
4.8.1 MediGene AG Profile
Table MediGene AG Overview List
4.8.2 MediGene AG Products & Services
4.8.3 MediGene AG Business Operation Conditions
Table Business Operation of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 NGM Biopharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.9.1 NGM Biopharmaceuticals, Inc. Profile
Table NGM Biopharmaceuticals, Inc. Overview List
4.9.2 NGM Biopharmaceuticals, Inc. Products & Services
4.9.3 NGM Biopharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Virobay Inc. (Company Profile, Sales Data etc.)
4.10.1 Virobay Inc. Profile
Table Virobay Inc. Overview List
4.10.2 Virobay Inc. Products & Services
4.10.3 Virobay Inc. Business Operation Conditions
Table Business Operation of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Primary Biliary Cirrhosis Drug Sales Revenue 2015-2019, by Company, in USD Million
Table Global Primary Biliary Cirrhosis Drug Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Primary Biliary Cirrhosis Drug Sales Revenue Share in 2019, by Company, in USD Million
Table Global Primary Biliary Cirrhosis Drug Sales Volume 2015-2019, by Company, in Volume
Table Global Primary Biliary Cirrhosis Drug Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Primary Biliary Cirrhosis Drug Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Primary Biliary Cirrhosis Drug Market Concentration, in 2019
Figure Europe Primary Biliary Cirrhosis Drug Market Market Concentration, in 2019
Figure Asia-Pacific Primary Biliary Cirrhosis Drug MMarket Concentration, in 2019
Figure South America Primary Biliary Cirrhosis Drug Market Concentration, in 2019
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Clinic
Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2015-2019, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2015-2019, in Volume
6.1.2 Demand in Hospital
Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2015-2019, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2015-2019, in Volume
6.1.3 Demand in Others
Figure Primary Biliary Cirrhosis Drug Demand in Others, 2015-2019, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Primary Biliary Cirrhosis Drug Demand Forecast 2020-2025, by Application, in USD Million
Figure Primary Biliary Cirrhosis Drug Market Growth 2020-2025, by Application, in USD Million
Figure Primary Biliary Cirrhosis Drug Market Share in 2025, by Application, in USD Million
Table Primary Biliary Cirrhosis Drug Demand Forecast 2020-2025, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Market Growth 2020-2025, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Primary Biliary Cirrhosis Drug Production 2015-2019, by Region, in USD Million
Table Primary Biliary Cirrhosis Drug Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Primary Biliary Cirrhosis Drug Market 2015-2019, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Share 2015-2019, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2015-2019, by Region, in Volume
Table Global Primary Biliary Cirrhosis Drug Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2015-2019, in USD Million
Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in USD Million
Table North America Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2015-2019, in USD Million
Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in USD Million
Table Europe Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2015-2019, in USD Million
Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in USD Million
Table South America Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Primary Biliary Cirrhosis Drug Market Forecast 2020-2025, by Region, in USD Million
Table Primary Biliary Cirrhosis Drug Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of Primary Biliary Cirrhosis Drug
Table Application Segment of Primary Biliary Cirrhosis Drug
Table Global Primary Biliary Cirrhosis Drug Market 2015-2025, by Application, in USD Million
Table Major Company List of FFP-104
Table Major Company List of GSK-2330672
Table Major Company List of MBX-8025
Table Major Company List of NGM-282
Table Major Company List of Others
Table Global Primary Biliary Cirrhosis Drug Market 2015-2019, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2015-2019, by Type, in Volume
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2020-2025, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2020-2025, by Type, in Volume
Table AlbireoPharma Overview List
Table Business Operation of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CymaBay Therapeutics, Inc. Overview List
Table Business Operation of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Falk Pharma GmbH Overview List
Table Business Operation of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Enanta Pharmaceuticals, Inc. Overview List
Table Business Operation of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Plc Overview List
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intercept Pharmaceuticals, Inc. Overview List
Table Business Operation of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MediGene AG Overview List
Table Business Operation of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NGM Biopharmaceuticals, Inc. Overview List
Table Business Operation of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Virobay Inc. Overview List
Table Business Operation of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Primary Biliary Cirrhosis Drug Sales Revenue 2015-2019, by Company, in USD Million
Table Global Primary Biliary Cirrhosis Drug Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Primary Biliary Cirrhosis Drug Sales Volume 2015-2019, by Company, in Volume
Table Global Primary Biliary Cirrhosis Drug Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Primary Biliary Cirrhosis Drug Demand Forecast 2020-2025, by Application, in USD Million
Table Primary Biliary Cirrhosis Drug Demand Forecast 2020-2025, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Market Growth 2020-2025, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Market Share in 2025, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Production 2015-2019, by Region, in USD Million
Table Primary Biliary Cirrhosis Drug Production 2015-2019, by Region, in Volume
Table Global Primary Biliary Cirrhosis Drug Market 2015-2019, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Share 2015-2019, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2015-2019, by Region, in Volume
Table Global Primary Biliary Cirrhosis Drug Market Share 2015-2019, by Region, in Volume
Table North America Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in USD Million
Table North America Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in Volume
Table Europe Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in USD Million
Table Europe Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in Volume
Table South America Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in USD Million
Table South America Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2015-2019, by Country, in Volume
Table Primary Biliary Cirrhosis Drug Market Forecast 2020-2025, by Region, in USD Million
Table Primary Biliary Cirrhosis Drug Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
